En ensayos clnicos como SURPASS y SURMOUNT, la tirzepatida ha mostrado reducciones significativas de hemoglobina A1c (hasta 2.0-2.5% con dosis de 15 mg) y prdida de peso sustancial (15-22% del peso corporal inicial en estudios de 72 semanas), adems de mejoras en factores de riesgo cardiometablico como presin arterial y perfil lipdico
due to gastro-intestinal adverse events) and gastro-intestinal adverse events (patients reporting at least one episode of C
DU HIU THIU HT BIOTIN Nhng du hiu cho thy bn b thiu ht biotin (vitamin H): - Tc mng, rng nhiu - y l du hiu d nhn bit nht - Da kh, sn si - Pht ban , trc vy, thng quanh mt, mi v ming - Mng tay gin, d gy - Kh mt - Tm trng tht thng, d cu gt - Mt mi, chn n, kh ng - T v nga ran chn tay Nhng i tng d b thiu biotin Tnh trng thiu biotin t khi xy ra bi c th chng ta ch cn mt lng rt nh v biotin c mt trong nhiu loi thc phm quen thuc
Muller, P
Tesamorelin is not currently FDA approved as a treatment for fatty liver disease, metabolic dysfunction-associated steatotic liver disease, or general liver-fat reduction
This article is for educational purposes only and does not replace the advice of a qualified healthcare or nutrition professional